Spots Global Cancer Trial Database for endoxana, leukine, ima910, aldara
Every month we try and update this database with for endoxana, leukine, ima910, aldara cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) | NCT00785122 | Colorectal Carc... | Endoxana, Leuki... Endoxana, Leuki... | 18 Years - | Immatics Biotechnologies GmbH | |
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) | NCT00785122 | Colorectal Carc... | Endoxana, Leuki... Endoxana, Leuki... | 18 Years - | Immatics Biotechnologies GmbH |